The discovery that samples of many types of human tumor will grow progressively when implanted into athymic 'nude' mice represents a milestone in the study of human neoplasia. Though this technique - referred to as 'xenografting' - is used throughout the world as a routine method in cancer research, it nevertheless suffers from one serious limitation, and that is a failure of the implanted tumor to metastasize in almost all instances. Thus, such grafts assume a non-malignant behaviour even if the tumor was highly malignant in its original (human) host. When metastases do manifest themselves, the pattern is usually not reflective of the clinical behaviour of the tumor.
Our aim i s to isolate and characterize heritable and phenotypically stable mutant cell lines from human melanomas (and eventually from other types of tumors) which not only will readily metastasize in nuce mice, but which will do so in a manner that faithfully reproduces their usual clinical behaviour. Our guiding hypothesis, based primarily on recent work in our laboratory, is that such cell subpopulations exist in very low frequencies but can be isolated through the selection of so-called lectin resistant (Lec-r) 'glycosylation mutants'. These are cells which usually possess cell surface carbohydrate alterations the nature of which, at least in some cases, can endow cells with unique metastatic abilities, (including tumor cells of human origin growing in nude mice). Because Lec-r mutants appear to arise in most instances as a consequence of point or deletion mutations, the cell populations comprising them are invariably stable and highly homogeneous for their altered - and sometimes unique - lectin resistant and metastatic phenotypes. Thus, they are excellent cell populations with which to initiate studies aimed at identifying cell surface biochemical (structural) features and genes relevant to the expression of the metastatic phenotype- the second major aim of this proposal. Clearly, the availability of such well-defined human tumor mutant cell populations displaying clinically-relevant metastatic phenotype in nude mice would be a valuable resource for human cancer cell biology research studies, in general and for oncology studies involving experimental therapeutics in vivo, in particular.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA041233-02
Application #
3181508
Study Section
Metabolic Pathology Study Section (MEP)
Project Start
1986-01-01
Project End
1988-12-31
Budget Start
1987-01-01
Budget End
1987-12-31
Support Year
2
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Mount Sinai Hospital (Toronto)
Department
Type
DUNS #
City
Toronto
State
ON
Country
Canada
Zip Code
Finer-Moore, Janet S; Lee, Tom T; Stroud, Robert M (2018) A Single Mutation Traps a Half-Sites Reactive Enzyme in Midstream, Explaining Asymmetry in Hydride Transfer. Biochemistry 57:2786-2795
Kerbel, Robert S (2015) A Decade of Experience in Developing Preclinical Models of Advanced- or Early-Stage Spontaneous Metastasis to Study Antiangiogenic Drugs, Metronomic Chemotherapy, and the Tumor Microenvironment. Cancer J 21:274-83
Kuczynski, Elizabeth A; Lee, Christina R; Man, Shan et al. (2015) Effects of Sorafenib Dose on Acquired Reversible Resistance and Toxicity in Hepatocellular Carcinoma. Cancer Res 75:2510-9
Cruz-Muñoz, William; Di Desidero, Teresa; Man, Shan et al. (2014) Analysis of acquired resistance to metronomic oral topotecan chemotherapy plus pazopanib after prolonged preclinical potent responsiveness in advanced ovarian cancer. Angiogenesis 17:661-73
Kerbel, Robert S; Guerin, Eric; Francia, Giulio et al. (2013) Preclinical recapitulation of antiangiogenic drug clinical efficacies using models of early or late stage breast cancer metastatis. Breast 22 Suppl 2:S57-65
Guerin, Eric; Man, Shan; Xu, Ping et al. (2013) A model of postsurgical advanced metastatic breast cancer more accurately replicates the clinical efficacy of antiangiogenic drugs. Cancer Res 73:2743-8
Hackl, Christina; Man, Shan; Francia, Giulio et al. (2013) Metronomic oral topotecan prolongs survival and reduces liver metastasis in improved preclinical orthotopic and adjuvant therapy colon cancer models. Gut 62:259-71
Milsom, Chloe C; Lee, Christina R; Hackl, Christina et al. (2013) Differential post-surgical metastasis and survival in SCID, NOD-SCID and NOD-SCID-IL-2R?(null) mice with parental and subline variants of human breast cancer: implications for host defense mechanisms regulating metastasis. PLoS One 8:e71270
Kuczynski, Elizabeth A; Sargent, Daniel J; Grothey, Axel et al. (2013) Drug rechallenge and treatment beyond progression--implications for drug resistance. Nat Rev Clin Oncol 10:571-87
Cruz-Muñoz, William; Jaramillo, Maria L; Man, Shan et al. (2012) Roles for endothelin receptor B and BCL2A1 in spontaneous CNS metastasis of melanoma. Cancer Res 72:4909-19

Showing the most recent 10 out of 111 publications